THE FRIDAY THE 13TH CONVERTIBLE NOTE

New Post Public Reply Private Reply Replies (0) Message Board
jonny_red32
261
THE FRIDAY THE 13TH CONVERTIBLE NOTE MASSACRE

2018-04-12
HEY CONVERTIBLE NOTE HOLDERS – LET’S MAKE A DEAL!
 
Turns out that Friday the 13th is also unlucky for toxic convertible note-holders! I have been warning the toxic convertible note industry that there was going to be a reckoning with regard to how they lend money to microcap OTC Markets companies, and now, it seems that the chickens are coming home to roost. Several months ago COR Clearing decided to make it near impossible to clear any stock derived through convertible notes coming from OTC Market issuers.  That decision was based largely on several issues, they key being that a convertible note is not a security that would allow an opinion to clear stock under a Rule 144 exemption.  I won’t get into the legalities of this here other than to say to look up both the New Earthshell v. Jakoobit case in the US District Court for the Southern District of New York, as well as the Reves v Ernst & Young US Supreme Court case. In the end, COR Clearing made a good decision – but not good for toxic convertible note holders. In fact, I had a well-known lenders counsel from Florida send me an article he wrote that tried to counter the courts decisions – that was a massive FAIL!  Well, as of Friday, April 13, 2018, one of the last major clearing houses, ALPINE, is stopping processing stock from convertible notes from issuers trading sub-penny (most are sub-penny after being pummeled by toxic convertible notes). Turns out that Friday the 13th is also unlucky for note-holders! Now-what note-holders?  Your sometimes arrogant and greedy attitudes in dealing with small undercapitalized issuers needs to change and it needs to change quickly if you are going to save all that money on the street - instead of being worth 5 times that amount, being worth less than half of its principle value and in some instance, worth nothing.
 
Here’s how I see it – The options are limited:
 
Sell the note to a third party– Good luck with that.  That was a viable alternative when the third party could easily benefit from tacking provisions from the date of the original transaction, but now the challenge is finding a clearinghouse, on shore, that would clear that stock. If you think someone will buy the note just to collect the principle and stated interest, think again. Not likely as most of your borrowers don’t have sufficient assets to take should your successor ever get a judgment. The only way to get rid of that note now is to sell it at a substantial discount to its face value, and again, good luck with that, you will be throwing money away if your lucky to find someone stupid enough to buy it.
 
Wait for Maturity then Get a Judgment– Good luck with that also. Most of the issuers have limited assets and limited revenues and it’s highly unlikely that you would ever collect. Plus, you will incur legal fees to commence, litigate, adjudicate, secure and collect on a judgment (if you can). On a note under $50,000.00, it’s just not worth it. That would just be throwing good money after bad. Almost every toxic note lender I come across has not been able to collect on judgments they obtain in either state or federal court relying instead on the tactic that once they get a judgment the issuer will fold and settle and fork over cash and/or free trading stock. In some cases litigation forces the companies out of business. They will probably just start all over again without you.
 
A 3(a)(10) Court Approved Settlement– Possibly, but the courts are starting to catch on to this end-around and have been denying approving such settlements.  Also, the costs and documentation to get a 3(a)(10) settlement is almost prohibitive, but it is an option provided your issuer agrees to it.  Based on the first two options the issuers may hurt their chances of doing a real deal that could benefit both sides, if they agreed to a 3(a)(10) settlement too early.
 
Give up and let the Loan Sit- Always an option.  Many issuers experience a toxic note-holder who will sit on its' hands and wait it out, sometimes for years, hoping the company’s stock price improves or the issuer somehow is able to bring its' financial reporting requirements current, or better yet, some magical mystery investor that will hand over cash to pay off the notes. There are only a handful of lenders, mostly out of New York, Chicago and Massachusetts that will try on litigation to force you to settle or come up with money to pay them off. Usually, they want to force issuance of shares or they want a new deal for more shares – either way, its back to the prior discussed problems of clearing the stock. They may even try suing the CEO personally under some BS fraud claim and as we know now under the Jakoobit case, a convertible note may not be a security and if it’s not a security, there can be no securities fraud claims.  Then its simple state based fraud claim and in most states, if there is a breach of contract claim, the fraud claim against the CEO personally usually fails.
 
LETS MAKE A DEAL!
 
I have seen how entrenched these toxic note-holders are in how they have previously approached some of my clients. The funny thing is that every time we contest litigation based on certain usury statutes under state law, they jump up and down claiming that the notes are investments instead of loans.  Well, ALL of the courts are now finding that these transactions all start out as loans. But the point here is that they “claim” they are investments even though the investment decision is made when they convert months after the original loan is made. So if they are an “investor” from the beginning, that means by definition they are taking a “risk” in the company’s success – yea, right. We all know the true and sole motivation of providing these types of loans and it certainly is NOT based on the success of the issuer but rather, on trading price and volume of the issuers public stock.
 
The cold hard reality is that from an economic position, the note-holders have just lost a tremendous amount of leverage and some of you CEO’s whose company stocks have been crippled by these transactions and those who have been tortured by message board posters would instinctively want to take revenge and put the screws to them.  BUT WAIT! There is a solution that makes sense that is legal and puts both the issuer and the lender on better footing. The plan for a new class of convertible preferred equity designed solely to allow the convertible note holder to actually use the booked liability to really “invest”, short term, into the company. My group has been using this method of debt remediation rather successfully with no issues other than some lender pushback. Now with APLINE’s Friday the 13th massacre, I think that will change as well. The lender eventually gets what it wants out of the deal; the issuer gets the liabilities removed from its balance sheet allowing them to go out and raise more traditional capital; the pressure on the stock is alleviated, no more lawsuits, no more angst, its really a win-win for both sides. Less booked liabilities, more capital is available improving the company’s financial outlook, and in 6 or 12 months, the former lender, and now shareholder, can convert into common with no clearing issues.
 
In discussing Apline’s newest position with one of my clients CEO’s, Bob Silzer of DSG Global, Inc., a great company that is revolutionizing the golf information industry, we agreed that most OTC Markets companies should consider a fair and reasonable restructuring that can clean up their books, eliminate booked liabilities yet provide a similar return to their note-holders under a fair program where both sides win. It’s very hard to try to convince someone that their business model needs to change, but if change provides you with a similar or same return, then why all the pushback? The days of lenders forcing their position seem to be quickly coming to an end because the major clearing houses will not clear stock from convertible notes and the sooner these lenders realize that convertible preferred stock arrangement can allow them to realize similar returns while helping the companies they “invest” in to focus on their business to make it more successful can benefit everyone including its shareholders. 
 
It could very well be that the current landscape for convertible notes is changing and I can only suggest that the lenders quickly, post-haste, contact their issuers now to work out a deal in which everyone wins. I also encourage the issuers, no matter how mad you are at the note-holders, to be receptive and deal with them fairly and provide them with a real investment structure to help them realize a return on the monies loaned to your company. At the end of the day its not only about the deal you make, but rather, being part of the solution that is way more rewarding than being the actual problem.
 
 
Mark R. Basile, Esq. is a nationally known corporate restructuring and workout attorney and is a member of The Basile Law Firm P.C. The Firm represents numerous OTC and Pink Sheet companies in litigation and corporate restructurings. www.thebasilelawfirm.com. Mr. Basile is also director of OTCWORKOUTS LLC www.otcworkouts.com
Engineer by trade & Swing Trader at Heart!

Join Webull today and get up to 75 #FREE stocks!
Get started >> Register with my referral link now>> JOIN HERE NOW


CLICK TO SEE --> Engineer, Design,& Build Packaging Equipment






Scroll down for more posts ▼

Top 10 Most Recent News Articles

Switzerland Launches Europe's First Spot Bitcoin ETF

Updated Category News Views 0

Switzerland: A Crypto Game Changer You hear that ding? That’s the sound of opportunity knocking over in Switzerland's backyard. BIT Asset Management AG has scored the first-ever FINMA-approved spot Bitcoin ETF in Europe, setting the bar higher for those who fancy getting cozy with digital assets. So let's dive right into this Swiss sensation—because, folks, you gotta...

Continue Reading
ILS and Anduin Join Forces to Streamline Fundraising

Updated Category News Views 3

Big Moves in Legal Tech and Fundraising In the world of investing, where technology is always a step ahead, Intelligent Legal Solutions (ILS) and Anduin are cooking up a storm with their latest partnership announcement. Targeting private markets fund managers and law firms, these two tech players aim to ease the layered chaos that comes with fundraising by integrating...

Continue Reading
Shareholder M&A Alert: Is the Deal Fair?

Updated Category News Views 5

A Closer Look at the Deals in Question It seems every other day another company’s deciding to shack up with a new partner, but are those deals really all they’re cracked up to be? Here’s a rundown of some fresh cases launching shareholder class actions probing the fairness of recent transactions. Big names on the list? Bowman Consulting, DoubleVerify, Varex Imaging,...

Continue Reading
deepset Strikes with AI Cost Solutions for Key Sectors

Updated Category News Views 10

The AI Cost Conundrum: deepset's Strategic Leap deepset's latest move unleashes a fresh wind in the AI sector, tackling the financial drag from running high-caliber AI agents. With its Haystack Enterprise Platform, deepset isn't just coddling around the edges—it's going for the heart, where the budget bleeds most, and patching it up with a tech-savvy twist. Surfing the...

Continue Reading
Century Communities' Bold Move in Southwest Fresno

Updated Category News Views 7

A Fresh Start in an Overlooked Market Century Communities just kicked the dust off Southwest Fresno, a spot that was almost forgotten by big developers. With their grand opening of Traditions at West Creek Village, they’re not just building homes; they’re igniting a local rejuvenation. This place hasn’t seen a major residential development push like this in ages,...

Continue Reading
Fresenius Revamps U.S. Kidney Care with multiFiltratePRO

Updated Category News Views 6

Fresenius Takes a Giant Leap in Kidney Care Fresenius Medical Care is breaking new ground in the U.S., marking a significant milestone with the introduction of the multiFiltratePRO System for critically ill patients battling acute kidney injury (AKI). This isn't some run-of-the-mill equipment upgrade. It's an evolution in how critical care teams manage continuous kidney...

Continue Reading
CMCC Global Pioneers Tokenized Funds in El Salvador

Updated Category News Views 0

A Bold Move into Tokenization Tokenization: it's the buzzword that's got folks scratching their heads and bankers keeping an extra bottle of aspirin in their desk drawers. CMCC Global is diving headlong into this brave new world, rolling out two tokenized fund-of-funds right under El Salvador's fresh digital asset rules. Now that's gutsy. The Partners in Innovation...

Continue Reading
Paige Kaplan Randolph Spotlights on Hollywood Power List

Updated Category News Views 2

From Law Books to Power Lists Cue the applause, folks! Paige Kaplan Randolph has just snagged a shiny badge of honor being named to The Hollywood Reporter's Power Reps: Creators List for 2026. This ain't some random nod; it's a recognition spotlighting legal stalwarts shaping the ever-morphing mosaic of entertainment. If you're wondering where the real power behind the...

Continue Reading
Microtubule Defects Revealed: Impacts on Cancer Treatment

Updated Category News Views 4

Peering into the Heart of Microtubules Ever squint at a tapestry, only to find a rogue thread ruining the pattern? Well, that’s somewhat what scientists at Kanazawa University have found with microtubules, those tiny rods in our cells that usually keep it all together. Using some pretty fancy tech called high-speed atomic force microscopy, these folks peered into the...

Continue Reading
Visteon Reports Q3 2026 Results with Mixed Signals

Updated Category News Views 0

Visteon's Q3 2026 Financial Performance: Insights and Implications You'd think by now that anything to do with supply chain hiccups wouldn’t surprise me, but Visteon Corporation’s recent third quarter results got my gears grinding yet again. Here's the scoop: Visteon pulled in $970 million in sales, strutting around with a 10% growth-over-market. Their resilience...

Continue Reading

Top 5 Most Recently Viewed Articles

O3 Mining Strengthens Kinebik Project via Lac Esther Property

Updated Category News Views 58

O3 Mining Expands Kinebik Project with Lac Esther Acquisition TSXV: OIII | OTCQX: OIIIF - O3 Mining O3 Mining Inc. (TSXV: OIII) (OTCQX: OIIIF) has announced an exciting development regarding the Lac Esther property, which will bolster its ongoing Kinebik Project. This acquisition positions O3 Mining to enhance its strategic exploration efforts in the rich Casa Berardi...

Continue Reading
Thyme&Table™ Unveils Stunning New Kitchen Appliance Colors

Updated Category News Views 117

Thyme&Table™ Introduces Vibrant Colors for Kitchen Appliances Thyme&Table™, renowned for its innovative and stylish kitchen electronics, has taken significant steps forward by unveiling a fresh array of colors in its premier collection. From sophisticated Cabernet Red to the calming tones of Eucalyptus Green, these new colors not only enhance the visual appeal of...

Continue Reading
Aquafil S.p.A. to Showcase Sustainability at Investor Event

Updated Category News Views 72

Aquafil S.p.A. to Highlight Sustainability at Investor Event Aquafil S.p.A. is gearing up to make a notable impact at the upcoming Lytham Partners Fall 2024 Investor Conference. Renowned for its innovative efforts in the circular economy, Aquafil will take part in a webcasted presentation and hold one-on-one meetings with prospective investors. The event, which will take...

Continue Reading
AIRS Medical's Global Expansion Revolutionizing Imaging Technology

Updated Category News Views 191

AIRS Medical's Ambitious Global Expansion AIRS Medical has been making waves in the healthcare sector with its innovative AI-driven MRI solution, SwiftMR. This groundbreaking technology is not just enhancing image quality; it's also significantly speeding up the diagnostic process, making it a valuable asset for healthcare providers. Currently, AIRS Medical operates out...

Continue Reading
Infosys and Anthropic: AI Play or Just Hype?

Updated Category News Views 165

Infosys has just unveiled a major partnership with Anthropic, launching a strategic collaboration focused on harnessing AI across complex industries like telecommunications and financial services. The game plan? Create an Anthropic Center of Excellence to craft bespoke AI agents that can tackle real-world challenges—think automated compliance checks and optimized...

Continue Reading